Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

843.73
-2.4432-0.29%
Number of Gainers:17
Number of Losers:30
Number of Flat:8
PE:- -
High:845.97
Open:845.97
Low:841.17
Close:846.17
Volume:8.27M
Turnover:82.02M
Market Cap:143.96B
Float Cap:85.27B

Loading ...

Kanzhun Ltd. files HKEX next day disclosure return reporting 1,129,280 new shares issued at USD 0.71 each

Reuters
·
Mar 23

BOSS Zhipin-W Grants 2.9 Million Share-Based Awards to Employees

Stock News
·
Mar 22

Kanzhun grants 2,897,640 RSUs to 70 employees under post-IPO share scheme

Reuters
·
Mar 22

Kanzhun Grants Nearly 2.9 Million RSUs to Employees Under Post-IPO Incentive Plan

TIPRANKS
·
Mar 22

Xiaomi CEO Lei Jun Issues Public Apology for Technical Misstatement

Deep News
·
Mar 22

Is RPC (RES) Fairly Priced After Its Strong Multi Year Share Price Performance

Simply Wall St.
·
Mar 22

Is GDS Holdings (GDS) Pricing In Too Much Optimism After Its 120% Three-Year Rally?

Simply Wall St.
·
Mar 21

Human Connection Remains Irreplaceable Despite AI Advances, Says Yu Minhong

Deep News
·
Mar 21

CEO Yu Minhong: EAST BUY's Core Identity is Product-Centric, Not Livestreaming

Deep News
·
Mar 21

Xinjiang Railway Unveils Enhanced Tourism Offerings to Boost Cultural and Travel Integration

Deep News
·
Mar 21

Jay Chou Exclusive Tests Tencent Music’s Fan Economy And Dividend Story

Simply Wall St.
·
Mar 21

HM Exploration Launches C$1.5 Million LIFE Flow-Through Financing for Critical Minerals Exploration

TIPRANKS
·
Mar 21

Oklo And Centrus Fuel Venture Adds New Angle To Valuation Debate

Simply Wall St.
·
Mar 21

Major Stake Shift: Insider’s Bold Exit from Mohawk Stock Shakes Up Market Watchers

TIPRANKS
·
Mar 21

BRIEF-Regenxbio Enters Settlement And Release Agreement With Glaxosmithkline On March 18, 2026 - SEC Filing

Reuters
·
Mar 21

Regenxbio Inc - to Continue to Pay GSK Amounts Received From Sublicensees Pursuant to Existing Sublicense Agreements - SEC Filing

THOMSON REUTERS
·
Mar 21

Regenxbio Inc - Enters Settlement and Release Agreement With Glaxosmithkline on March 18, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 21

Regenxbio Inc - to Pay $10.0 Mln to Glaxosmithkline for Alleged Underpayment of Sublicense Fees - SEC Filing

THOMSON REUTERS
·
Mar 21

Press Release: HM Exploration Announces $1.5 Million LIFE Flow-Through Offering

Dow Jones
·
Mar 21

Top News Today: Stocks Slide, Treasury Yields Rise Amid Oil Shock

Dow Jones
·
Mar 21